<DOC>
	<DOCNO>NCT01618123</DOCNO>
	<brief_summary>It recognize endothelial dysfunction major factor contribute atherogenic process . Abnormal function endothelium detectable prior obvious intimal lesion patient risk factor atherosclerosis . Endothelial dysfunction systemic disorder key variable pathogenesis atherosclerosis complication . Measurement peripheral vasodilator response fingertip peripheral arterial tonometry ( PAT ) technology ( EndoPAT ; Itamar Medical , Caesarea , Israel ) emerge useful method assess vascular function . EndoPAT may potential valid test increase accuracy , sensitivity specificity detection subject chest pain unit ( CPU ) chest pain obvious coronary artery disease ( CAD ) . This relatively fast non-invasive bedside test , relatively low-cost side effect . Therefore , primary objective study test hypothesis abnormal endothelial function assess EndoPAT test increase prediction short ( in-hospital ) long-term ( 1-year ) outcome patient present chest pain unit .</brief_summary>
	<brief_title>Association Endothelial Function Clinical Outcomes Subjects Admitted Chest Pain Unit</brief_title>
	<detailed_description>All subject admit CPU low moderate probability CAD negative troponin , undergo follow test upon arrival follow clinical evaluation consent study : resting ECG , EndoPAT test stress nuclear image stress echocardiography . Except EndoPAT test , test conduct accord routine CPU protocol . The result EndoPAT blind treat physician end study patient manage accord current CPU protocol , include 24-h Holter monitoring , repeat rest ECG exercise test ( nuclear SPECT image stress echocardiography , whichever available ) addition repeat clinical troponin test evaluation . All clinical data recruit subject record evaluated completion study . Long-term clinical follow-up All patient follow telephone contact 6 12 month combine major adverse cardiovascular end-points ( MACE ) include all-cause mortality , non-fatal myocardial infarction , hospitalization heart failure angina pectoris , stroke , coronary artery bypass graft percutaneous coronary intervention , physician blind patient ' baseline clinical status endothelial function ( assessed EndoPAT ) result . All MACE validate review medical record senior cardiologist blind endothelial function result . In addition , on-line access information facilitate verification safe documentation event . In addition , write medical record review cardiologist event death , hospitalization and/or angina pectoris . At end study cost effectiveness prediction short ( in-hospital ) long ( 6 month , 1 year ) EndoPAT assess compare stress test ( nuclear image and/or echocardiography ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Chest Pain</mesh_term>
	<criteria>All subject admit CPU low moderate probability CAD negative troponin . Subjects chest pain positive troponin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Endothelial function</keyword>
	<keyword>Coronary disease</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Chest pain</keyword>
</DOC>